Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 08,2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citigroup Global Markets, acting as Manager to the Open Offer, has disclosed the number of shares tendered by public shareholders of Sanofi Consumer Healthcare India Limited as of May 8, 2025. The Open Offer is for acquisition of up to 59,87,962 equity shares (26% of voting share capital) by Opal Bidco SAS together with Clayton, Dubilier & Rice Fund XII, L.P. as persons acting in concert. A total of 23,96,014 equity shares have been tendered so far, representing 40.01% of the Offer Size, of which 1,22,355 shares (2.04% of the Offer Size) were tendered on May 8, 2025 alone. The tendered shares will undergo validation, and the number of shares validly accepted may differ from the total tendered.
Moderate tendering response (40% of offer size) suggests public shareholders are partially participating in the Open Offer. Final acceptance will follow SEBI (SAST) Regulations; shareholders who have not tendered yet may still have a window to participate before the offer closes.